References

  1. Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer. 2001;94(2):153-6. PubMed | Google Scholar

  2. Yu MC, Yuan JM. Environmental factors and risk for hepatocellular carcinoma. Gastroenterology. 2004 Nov;127(5 Suppl 1):S72-8. PubMed | Google Scholar

  3. Venook AP, Papandreou C, Furuse J, de Guevara LL. The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective. Oncologist. 2010;15(Suppl 4):5-13. PubMed | Google Scholar

  4. Altekruse SF, McGlynn KA, Reichman ME. Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol. 2009;27(9):1485-91. PubMed | Google Scholar

  5. McGlynn KA, London WT. Epidemiology and natural history of hepatocellular carcinoma. Best Pract Res Clin Gastroenterol. 2005;19(1):3-23. PubMed | Google Scholar

  6. Sherman M. Hepatocellular carcinoma: epidemiology, risk factors, and screening. Semin Liver Dis. 2005;25:143-54. PubMed | Google Scholar

  7. Trinchet JC, Alperovitch A, Bedossa P, Degos F, Hainaut P, Van Beers B. Epidémiologie, prévention, dépistage et diagnostic du carcinome hépatocellulaire. Bull Cancer. 2009; 96(1):35-43. PubMed | Google Scholar

  8. Blumberg BS, Larouze B, London WT, Werner B, Hesser JE, Millman I, Saimot G, Payet M. The relation of infection with the hepatitis B virus to primary hepatic carcinoma. Am J Pathol. 1975; 81(3):669-82. PubMed | Google Scholar

  9. Pham P, Saffroy R, Reffas M, Takka M, Lemoine A, Debuire B. Dépistage, diagnostic et suivi biologique du carcinome hépatocellulaire. Revue Francophone des Laboratoires. 2006;36(387):73-77. PubMed | Google Scholar

  10. Aghoram R, Cai P, Dickinson JA. Alpha-foetoprotein and/or liver ultrasonography for screening of hepatocellular carcinoma in patients with chronic hepatitis B. Cochrane Database of Systematic Reviews 2012 Issue 9 Art No: CD002799. PubMed | Google Scholar

  11. Bonnard P, Sombié R, Lescure FX , Bougouma A, Guiard-Schmid JB, PoynardT , Calès P, Housset C, Callard P, Le Pendeven C, Drabo J, Carrat F, Pialoux G. Comparison of elastography, serum marker scores, and histology for the assessment of liver fibrosis in hepatitis B virus (HBV)-infected patients in Burkina Faso. Am J Trop Med Hyg. 2010;82(3):454-458. PubMed | Google Scholar

  12. Bio Prédictive. http://www.biopredictive.com/intl/physician/fibrotest-for-hcv/. Site consulté le 03/01/2015

  13. Bosch FX, Ribes J, Borras J. Epidemiology of primary liver cancer. Semin Liver Dis.1999;19(3):271-85. PubMed | Google Scholar

  14. Bosch FX, Ribes J, Diaz M, Cleries R. Primary liver cancer: Worldwide incidence and trends. Gastroenterology. 2004;127(5 suppl 1):S5-S16. PubMed | Google Scholar

  15. Kew MC. Epidemiology of chronic hepatitis B virus infection, hepatocellular carcinoma, and hepatitis B virus-induced hepatocellular carcinoma. Pathologie Biologie. 2010;58 (4) :273-277. PubMed | Google Scholar

  16. Diarra M, Konate A, Dembele M, Kone B, Wandji Mj, Maiga My, Traore H. Carcinome hépatocellulaire: aspects épidémiologiques, cliniques et évolutifs. Médecine d'Afrique Noire. 2006;53(1):23-28. PubMed | Google Scholar

  17. Mahassadi KA, Attia KA, Bathaix YF, Kissi YH, Assohoun KT, Ndri-Yoman TH. Manifestations et facteurs cliniques prédictifs du carcinome hépato-cellulaire à Abidjan (Côte d'Ivoire) Etude rétrospective de 89 cas. Médecine d'Afrique noire.2005;52(11):601-608. PubMed | Google Scholar

  18. Parkin DM, Lisani P, Ferlay J. Estimates of the worldwide incidence of 25 major cancers. Int J Cancer.1999;80(6):827-841. PubMed | Google Scholar

  19. Njoya O, Tagny Tayou, Kamga JP, Ongolo Zogo P, Ndjitoyap-Ndam EC, Gonsu J. Traitement du carcinome hépatocellulaire par injection percutanée d'éthanol absolu au Cameroun. Médecine d'Afrique Noire. 2000;47(12):532-536. PubMed | Google Scholar